3658 results for «247»

Filter By

3658 results

Rapid-fire - Transcatheter interventions for tailed mitral valve prosthesis

18 Feb 2024 – From PCR Tokyo Valves 2024

This session of rapid-fire submitted cases focuses on transcatheter interventions for tailed mitral valve prosthesis. Learn about unusual solutions, such a reversed loop and parallel wiring to close crescent mitral paravalvular leak, base-to-tip LAMPOON and IABP during a successful mitral valve-in-valve, and more!

Rapid-fire - Transcatheter interventions for tailed mitral valve prosthesis

Rapid-fire - Bailout in SHD

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights into the bailout techniques in structural heart disease intervention in this session of rapid-fire submission cases (in Japanese).

Complex diagnosis

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights in how to deal with complex diagnoses in this session of rapid-fire submissions cases [in Japanese].

Nightmare in mitral valve interventions: sharing solutions together

18 Feb 2024 – From PCR Tokyo Valves 2024

This selection of cases showcase nightmare scenarios during mitral valve interventions. Find out what difficulties might arise during MitraClip procedure, and learn how to prevent complications through optimal treatments and bailouts.

Nightmare in mitral valve interventions: sharing solutions together

New devices for aortic intervention

18 Feb 2024 – From PCR Tokyo Valves 2024

In this session, discover a variety of abstract submissions concerning new devices for aortic intervention. Compare the clinical outcomes of the latest intra-annular devices, examine the differences in debris between SEV and PEV, and learn about PVL improvement after TAVI with a self-expanding valve.

New devices for aortic intervention

Rapid-fire - Bailout in TAVI

18 Feb 2024 – From PCR Tokyo Valves 2024

As TAVI is never risk-free, learn about bailout techniques to counter various complications through this series of rapid-fire case submissions. This session explores cases such as a transcatheter aortic valve distortion following cardiopulmonary resuscitation, acute transcatheter aortic valve migration into the left ventricle, and valve embolization.

Rapid-fire - Bailout in TAVI

TEER for primary mitral regurgitation

18 Feb 2024 – From PCR Tokyo Valves 2024

What are the current indications and future perspectives of using TEER for primary mitral regurgitation? Join this session if you want to gain insight into anatomical evaluation before TEER, learn the procedural strategy for complex primary mitral regurgitation, and explore the specific features of both MitraClip...

TEER for primary mitral regurgitation

TAVI optimisation

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this series of slides to enhance your understanding of TAVI optimisation through selected studies for PCR Tokyo Valves 2024. Learn about the prognostic value of right ventricle dysfunction after TAVR, explore a risk model in dialysis patients following TAVR, and explore the impact of age...

TAVI optimisation

Rapid-fire - Mitral TEER for complex situations

18 Feb 2024 – From PCR Tokyo Valves 2024

This series of rapid-fire submitted cases focuses on mitral TEER for complex situations. Learn about creative solutions to these situations such as clip inversion grasping, independent leaflet grasping with a CGA system, and more!

PCR Valves e-Course: Sponsored Programme

Prepare to ask questions and comments in the chat box during each sponsored session, and access Expert Interviews on key topics 24/7!
PCR Valves e-Course: Sponsored Programme

EuroIntervention: Meet Cory, your new AI Assistant!

26 Mar 2024

Since the launch of its new website in February, EuroIntervention has harnessed the power of AI, integrating this cutting-edge technology in the development and improvement of features such as an optimised user interface and a powerful search engine.

Introducing Cory, EuroIntervention's multilingual new AI assistant!

All-new EuroPCR 2021: what’s on?

Watch an interview with the Course Directors to discover all about the 4 live channels, 5 TV studios, 10 PCR Hubs worldwide and what’s on before, during and after EuroPCR!
EuroPCR 2021: what's on

MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.

15 May 2024

EuroPCR 2024 – Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

15 May 2024

Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...

Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data

19 Sep 2022

Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.

M. Pighi

Author

Michele Pighi
Bioprosthetic valve fracture in ViV-TAVR

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF

When transfemoral TAVI is not an option: rethinking alternative access strategies

18 Jun 2026

In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...

Author

Ulrich Schaefer
Alternative access, if transfemoral is not working

ILUMIEN IV: OPTIMAL PCI - Optical Coherence Tomography Guided Coronary Stent Implantation Compared with Angiography: A Multicenter Randomized Trial in Percutaneous Coronary Intervention

29 Aug 2023

Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...

Claudio Laudani

Author

Claudio Laudani
Daniele Giacoppo

Author

Daniele Giacoppo
ILUMIEN IV: OCT versus angiography
Didn’t find what you were looking for?